AMR Stakeholder Profile
Focus area/active in: Human Health | Animal Health | One Health | Therapeutics | Diagnostics
Company/Organisation type: SME
Copenhagen-based grit42 focuses on integrating digital laboratory infrastructure with user-friendly day-to-day lab workflows, as well as handling compound and sample logistics, in order to ensure structured quality data across all the different pre-clinical drug discovery phases. The specialists behind grit42 have more than 20 years of experience in solving complex data-focused problems in and around pre-clinical drug discovery for a variety of customers, including Novozymes, Sanofi, Lundbeck Pharma, Roche, LEO Pharma, the Gates Foundation, Ferring Pharma, as well as multiple EU-backed projects within Anti-Microbial Resistance.
These are the top three reasons to consider investing in the grit42 platform for pre-clinical drug discovery or research in and around Anti-Microbial Resistance.
Get in touch!
Lasse H. Görlitz
Please fill out the form below to get in touch with us.